• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » PLC Systems might not see 2011

PLC Systems might not see 2011

March 30, 2010 By MassDevice staff

PLCSF logo

PLC Systems Inc. (OTC:PLCSF) is on the ropes after ending 2009 in rough shape and is looking to drum up enough cash to stay in business.

PLC’s accountants are worried the company isn’t bringing in enough cash to stay in business, slapping the company with a so-called "going concern" opinion on its audit. That means Caturano & Co. has "substantial doubt about [PLC’s] ability to continue as a going concern for the next 12 months," according to a press release.

Fourth-quarter sales for the Franklin, Mass.-based medical device maker slid 28.1 percent to $901,000, compared with $1.3 million during the same period in 2008. Net losses for the quarter widened 172 percent to $603,000,or $ 2 cents per share, compared with $222,000 (1 cent per share) during Q4 2008.

Sales were down 11.6 percent during 2009, but PLC still managed to reduce net losses by 16.2 percent. The company posted net losses of $1.6 million, or 5 cents per share, on sales of $4.7 million during 2009. That compares with net losses of $1.9 million (6 cents per share) on sales of $5.3 million during the prior year.

PLC ended the year with just $2.6 million in cash (a little more than half of what it had at the end of 2008) and equivalents and liabilities of $2.9 million. The ongoing losses and negative cash flows from operations prompted its accountants Caturano & Co. to slap a "going concern" opinion in its audits of the company’s books. In February, PLC cut its workforce by a third and said it is examining the proverbial "strategic alternatives."

It’s been a rocky road for the company almost since it went public in in the mid-1990s, seeking to bring its transmyocardial laser revascularization technology to market. The company hit a bump with the Food & Drug Administration, which denied its first clearance application and asked it to go back to the laboratory for more clinical trial work. After regrouping and winning clearance, however, there just wasn’t enough cash left over to commercialize the product.

President and CEO Mark Tauscher told MassDevice last year that PLC‘s experience with the TMR device prompted a change in direction toward another device, the RenalGuard fluid management system.

That plan has met with some success, but the company has struggled to maintain its momentum. A series of international distribution deals — including one announced today covering Austria, New Zealand and Croatia — helped boost the top line, but bottom-line progress has been fitful.

In prepared remarks released today, Tauscher said the company is working with Natixis Bleichroeder LLC to find buyers for the RenalGuard technology and cited results from a clinical trial of the device consistent with positive data from a previous study.

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well Tagged With: PLC Systems Inc., Renal

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy